Evidence map›Paper›PMID 28605532›Full record

ReviewNeuro-oncology2017

PET imaging in patients with meningioma-report of the RANO/PET Group.

Norbert Galldiks, Nathalie L Albert, Michael Sommerauer, Anca L Grosu, Ute Ganswindt, Ian Law, Matthias Preusser, Emilie Le Rhun, Michael A Vogelbaum, Gelareh Zadeh and 4 more

Abstract readReview
In one paragraph

Review in Neuro-oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Guideline
  6. Prediction of Meningioma WHO Grade Using PET Findings: A Systematic Review and Meta-Analysis.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2021
    Pooled it
  7. Pooled it
  8. World journal of nuclear medicine · 2026
    Article
  9. Angiomatous meningioma with cystic degeneration: A case report.Experimental and therapeutic medicine · 2026
    Article
  10. Observational
  11. High-contrast somatostatin receptor imaging of meningiomas with [¹⁸F]SiTATE PET/CT.European journal of nuclear medicine and molecular imaging · 2026
    Article
  12. Review
  13. Review
  14. Combined SSTR2-targeted Analogue withFrontiers in oncology · 2026
    Article
  15. Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation.European journal of nuclear medicine and molecular imaging · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Norbert GalldiksDepartment of Neurology, University Hospital Cologne, Cologne, Germany.
Nathalie L AlbertDepartments of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany.
Michael SommerauerDepartment of Neurology, University Hospital Zurich, Zurich, Switzerland.
Anca L GrosuDepartment of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany.
Ute GanswindtDepartments of Radiation Oncology, Ludwig Maximilians-University of Munich, Munich, Germany.
Ian LawDepartment of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Matthias PreusserDepartment of Medicine I and Comprehensive Cancer Centre CNS Tumours Unit, Medical University of Vienna, Vienna, Austria.
Emilie Le RhunDepartment of Neurosurgery, University Hospital Lille, Lille, France.
Michael A VogelbaumDepartment of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA.
Gelareh ZadehDepartment of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
Frédéric DhermainDepartment of Radiation Oncology, Gustave Roussy University Hospital, Villejuif, France.
Michael WellerDepartment of Neurology, University Hospital Cologne, Cologne, Germany.
Karl-Josef LangenInstitute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany.
Jörg C TonnDepartments of Neurosurgery, Ludwig Maximilians-University of Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningiomas are the most frequent nonglial primary brain tumors and represent about 30% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly MRI or, rarely, CT. Most common treatment options are neurosurgical resection and radiotherapy (eg, radiosurgery, external fractionated radiotherapy). For follow-up after treatment, a structural imaging technique such as MRI or CT is used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as PET can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.

Indexed as

RadiopharmaceuticalsHumansMeningeal NeoplasmsMeningiomaPositron-Emission TomographyPrognosisRadiopharmaceuticalsligandmeningiomasMRIpositron emission tomographysomatostatin

Identifiers

PMID28605532
PMCPMC5716194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.